Prognostic Model of Hypertension

Recruiting

• Conditions: Hypertension
• Interventions: Other: Standard therapy

• Registration Number: NCT06160921
• Lead Sponsor: Xinjiang Medical University

Brief Summary

The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.

Detailed Description

The aim of the study is to establish a platform for monitoring, clinical research and translational medicine in Xinjiang, which aims to provide a basis for future quality improvement and research, and to promote efforts to improve the prognosis of patients with hypertension, and to translate research into improved care for patients, thereby reducing Morbidity and mortality associated with hypertension.

Study Timeline

• Study Start: 2020-01-01
• Study First Submitted: 2023-11-29
• Study First Submitted QC: 2023-12-06
• Study First Posted: 2023-12-07
• Status Verified: 2024-03
• Last Update Submitted: 2024-03-26
• Last Update Posted: 2024-03-28
• Primary Completion: 2030-01-01
• Study Completion: 2030-01-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 50000

Inclusion Criteria

• A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University

Exclusion Criteria

• Patients with secondary hypertension, patients with liver and kidney dysfunction,
• patients with mental disorders, and patients who are unwilling to participate in this trial

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
2	Standard therapy	-

Primary Outcome Measures

Name	Time	Method
Resistant hypertension	10 years of follow-up Resistant hypertension occurred during this period
Death (all-cause mortality, mortality from hypertension complications)	10 years of follow-up deaths occurred during this period

Secondary Outcome Measures

Name	Time	Method
Major adverse cardiovascular events	10 years of follow-up deaths occurred during this period

Trial Locations

Locations (1)

The First Affiliated Hospital of Xinjiang Medicial University; 🇨🇳 Ürümqi, Xinjiang, China